Swiss Stocks Extend Five-Year High as Novartis Gains

Swiss stocks rose for a second day, extending a five-year high, as drugmakers climbed and U.S. industrial production topped forecasts.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.